drugset / Trial / NCT02079649

Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for Allergic Conjunctivitis

NCT02079649 ↗

Phase 2 Completed 224 enrolled Alcon Research
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate two investigational ophthalmic solutions for reduction in ocular redness in subjects with allergic conjunctivitis.

Timeline

Start
2014-04
Primary completion
2014-07
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Subject AL-53817 Unknown 0.1 % Other
Subject AL-78843 Unknown 0.03 % Other
Comparator Dexamethasone Small molecule 0.1 % Other

Indications